↓ Skip to main content

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

Overview of attention for article published in Breast Cancer Research, March 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
30 Mendeley